top of page
Blog
Qiagen to acquire Parse Biosciences
QIAGEN has announced its plans to acquire Parse Biosciences, a rapidly growing company known for its instrument-free single-cell technology.
Nov 51 min read
ASHG 2025: The most important meeting in human genetics is now in Boston
The ASHG is currently hosting its 2025 Annual Meeting in Boston, the event brings together thousands of scientists, clinicians, and innovators from around the world.
Oct 151 min read
Illumina CEO envisions stable growth despite uncertainty
Thaysen assures that Illumina will achieve solid growth by 2027, driven by its commitment to multiomics and a strategy tailored to researchers.
Aug 291 min read
BioSkryb obtains an exclusive license for single-cell methylation patent
BioSkryb Genomics has obtained an exclusive license to a patent that enables combined DNA methylation and genomic variant analysis in a single cell
Aug 201 min read
Chan Zuckerberg Initiative, Innovative Genomics Institute Announce New Center for Pediatric CRISPR Cures
The last August 8th, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) announced the funding of the Center for Pediatric CRISPR Cures (Center).
Jul 151 min read
HiFi Long-Reads Uncover Elusive Variants in Rare Diseases
A new study analyzing these findings demonstrated that long-read sequencing (LRS) with PacBio HiFi genomes could overcome these problems and become a first-line test
Mar 11 min read
bottom of page